Correlation Between Vaxcyte and Bio Techne
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and Bio Techne Corp, you can compare the effects of market volatilities on Vaxcyte and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Bio Techne.
Diversification Opportunities for Vaxcyte and Bio Techne
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vaxcyte and Bio is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Bio Techne Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne Corp and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne Corp has no effect on the direction of Vaxcyte i.e., Vaxcyte and Bio Techne go up and down completely randomly.
Pair Corralation between Vaxcyte and Bio Techne
Given the investment horizon of 90 days Vaxcyte is expected to generate 1.6 times more return on investment than Bio Techne. However, Vaxcyte is 1.6 times more volatile than Bio Techne Corp. It trades about -0.1 of its potential returns per unit of risk. Bio Techne Corp is currently generating about -0.16 per unit of risk. If you would invest 9,434 in Vaxcyte on November 29, 2024 and sell it today you would lose (1,844) from holding Vaxcyte or give up 19.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vaxcyte vs. Bio Techne Corp
Performance |
Timeline |
Vaxcyte |
Bio Techne Corp |
Vaxcyte and Bio Techne Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaxcyte and Bio Techne
The main advantage of trading using opposite Vaxcyte and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Bio Techne vs. Biomarin Pharmaceutical | Bio Techne vs. Vaxcyte | Bio Techne vs. Liquidia Technologies | Bio Techne vs. Legend Biotech Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |